LSP2-9166 is a drug which acts as a selective agonist for the group III metabotropic glutamate receptors, with a reasonably potent EC50 of 70nM at mGluR4 and 220nM at mGluR7, and weaker activity of 1380nM at mGluR6 and 4800nM at mGluR8.

[1] It has anticonvulsant effects in animal studies,[2][3] and reduces self-administration of various addictive drugs.

[4][5][6]

This anticonvulsant-related article is a stub.

You can help Wikipedia by expanding it.